Neuromyelitis optica autoantibody (NMO-IgG) in patients with suspected NMO or limited forms of NMO

被引:0
|
作者
Zuliani, L.
Blanco, Y.
Tavolato, B.
Giometto, B.
Graus, F.
Saiz, A.
机构
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] S Antonio Hosp, Padua, Italy
[3] Ca Foncello Hosp, Treviso, Italy
来源
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S155 / S156
页数:2
相关论文
共 50 条
  • [21] Obstetric Outcomes in Mexican Patients with Nmo-IgG (+) Nmo
    Delgado-Garcia, Guillermo
    Chavez, Zoe
    Castillo-Garcia, Isaac
    Rodriguez-Chavez, Emmanuel
    Santos-Diaz, Marco
    Vargas-Santana, Sarah
    Rivas-Alonso, Veronica
    Corona-Vazquez, Teresa
    Flores-Rivera, Jose
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 78 - 78
  • [22] OSMS is NMO, but not MS: confirmed by NMO-IgG?
    Kikuchi, S
    Fukazawa, T
    LANCET NEUROLOGY, 2005, 4 (10): : 594 - 595
  • [23] NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy
    Kay, Claudia S. K.
    Scola, Rosana H.
    Lorenzoni, Paulo J.
    Jarius, Sven
    Arruda, Walter O.
    Werneck, Lineu C.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 148 - 150
  • [24] Revised diagnostic criteria for neuromyelitis optica - Incorporation of NMO-IgG status
    Jarius, Sven
    Paul, Friedemann
    Franciotta, Diego
    Aktas, Orhan
    Hohlfeld, Reinhard
    Zipp, Frauke
    Vincent, Angela
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (05): : E1 - E1
  • [25] Seroprevalence of NMO-IgG in multiple sclerosis with opticospinal presentation and neuromyelitis optica
    Maghzi, A. H.
    Mollabashi, M.
    Etemadifar, M.
    MULTIPLE SCLEROSIS, 2010, 16 (10): : 1288 - 1288
  • [26] Consequences of NMO-IgG binding to aquaporin-4 in neuromyelitis optica
    Rossi, Andrea
    Ratelade, Julien
    Papadopoulos, Marios C.
    Bennett, Jeffrey L.
    Verkman, A. S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (24) : E1511 - E1511
  • [27] Neuromyelitis optica spectrum disorder: the importance of NMO-IgG in clinical practice
    Radaelli, M.
    Martinelli, V.
    Moiola, L.
    Privitera, D.
    Dalla Libera, D.
    Rodegher, M.
    Colombo, B.
    Fazio, R.
    Furlan, R.
    Comi, G.
    JOURNAL OF NEUROLOGY, 2011, 258 : 101 - 101
  • [28] Japanese patients with NMO-IgG
    Fujihara, K.
    Nakashima, I.
    Misu, T.
    Takahashi, T.
    Watanabe, S.
    Nakamura, M.
    Miyazawa, I.
    Fujimori, J.
    Narikawa, K.
    Sato, S.
    Itoyama, Y.
    CURRENT TOPICS IN NEUROIMMUNOLOGY, 2006, : 21 - 25
  • [29] Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience
    Harirchian, Mohammad Hossein
    Aghamollaii, Vajiheh
    Tafakhori, Abbas
    Taslimi, Shervin
    Shahsiah, Reza
    Gholipour, Taha
    Mohammadi, Fatemehzahra
    Zare-Shahabady, Ameneh
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (01) : 98 - 104
  • [30] The significance of NMO-IgG positivity in neuromyelitis optica spectrum disorders: preliminary results
    Altintas, A.
    Nalbantoglu, M.
    Celik, R. G. Gozubatik
    Adibnia, Y.
    Kursun, A.
    Deniz, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 752 - 752